| Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model HC Dobinson, MM Gibani, C Jones, HB Thomaides-Brears, M Voysey, ... Clinical Infectious Diseases 64 (8), 1066-1073, 2017 | 70 | 2017 |
| A study of the prevalence and risk factors leading to HIV infection among a sample of street children and youth of Kathmandu D Karmacharya, D Yu, S Dixit, R Rajbhandari, B Subedi, S Shrestha, ... AIDS research and therapy 9, 1-7, 2012 | 30 | 2012 |
| Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model MM Gibani, C Jin, S Shrestha, M Moore, L Norman, M Voysey, E Jones, ... PLOS Neglected Tropical Diseases 14 (10), e0008783, 2020 | 23 | 2020 |
| Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model HB Juel, HB Thomaides-Brears, TC Darton, C Jones, E Jones, S Shrestha, ... Frontiers in immunology 8, 1916, 2018 | 23 | 2018 |
| Development and Evaluation of a Blood Culture PCR Assay for Rapid Detection of Salmonella Paratyphi A in Clinical Samples L Zhou, C Jones, MM Gibani, H Dobinson, H Thomaides-Brears, ... PloS one 11 (3), e0150576, 2016 | 22 | 2016 |
| Diagnostic host gene signature for distinguishing enteric fever from other febrile diseases CJ Blohmke, J Muller, MM Gibani, H Dobinson, S Shrestha, ... EMBO Molecular Medicine 11 (10), e10431, 2019 | 17 | 2019 |
| Molecular screening of major bacterial enteropathogens in human stool samples from diarrhoeal outbreak sites S Dixit, GP Bhandari, DB Karmacharya, S Shrestha, S Manandhar, ... Nepal Health Research Council, 2011 | 13 | 2011 |
| Genetic susceptibility to enteric fever in experimentally challenged human volunteers A Barton, J Hill, S Bibi, L Chen, C Jones, E Jones, S Camara, S Shrestha, ... Infection and immunity 90 (4), e00389-21, 2022 | 6 | 2022 |
| Investigating systemic immunity to typhoid and paratyphoid fever: characterising the response to re-challenge in a controlled human infection model M M Gibani, C Jin, H Thomaides-Brears, S Shrestha, L Precaido-Llanes, ... Open Forum Infectious Diseases 4 (suppl_1), S227-S228, 2017 | 6 | 2017 |
| Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised … SN Faust, R Haynes, CE Jones, N Staplin, E Whittaker, T Jaki, E Juszczak, ... The Lancet Child & Adolescent Health 8 (3), 190-200, 2024 | 5 | 2024 |
| Evaluation of autoantibody binding to cardiac tissue in multisystem inflammatory syndrome in children and COVID-19 vaccination–induced myocarditis H Patel, A Sintou, RA Chowdhury, S Rothery, AO Iacob, S Prasad, ... JAMA Network Open 6 (5), e2314291-e2314291, 2023 | 5 | 2023 |
| Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study S Shrestha, M Gurung, P Amatya, S Bijukchhe, AS Bose, MJ Carter, ... The Lancet Global Health 10 (10), e1494-e1504, 2022 | 5 | 2022 |
| Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal S Shrestha, LK Stockdale, MC Gautam, M Gurung, S Feng, P Maskey, ... The Journal of Infectious Diseases 224 (Supplement_3), S267-S274, 2021 | 2 | 2021 |
| Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study R Kandasamy, S Lo, M Gurung, MJ Carter, R Gladstone, J Lees, ... The Lancet Microbe 3 (7), e503-e511, 2022 | 1 | 2022 |
| Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children< 2 years of age SM Bijukchhe, M Gurung, B Pokhrel, M Shakya, D Pant, P Maskey, ... Vaccine, 2024 | | 2024 |
| Evaluation of acute and convalescent antibody concentration against pneumococcal capsular polysaccharides for the diagnosis of pneumococcal infection in children with community … MJ Carter, S Shrestha, P O’Reilly, P Gurung, M Gurung, S Thorson, ... The Pediatric Infectious Disease Journal 43 (2), e67-e70, 2024 | | 2024 |
| Early transcriptional responses to human enteric fever challenge A Barton, J Hill, D O'Connor, C Jones, E Jones, S Camara, S Shrestha, ... Infection and Immunity 91 (10), e00108-23, 2023 | | 2023 |
| Optimising DTwP-containing vaccine infant immunisation schedules (OptImms)—a protocol for two parallel, open-label, randomised controlled trials S Kelly, X Liu, K Theiss-Nyland, M Voysey, S Murphy, G Li, M Nyantaro, ... Trials 24 (1), 465, 2023 | | 2023 |
| COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case–control study with SARS-CoV-2 genetic sequencing SM Bijukchhe, PJ O'Reilly, K Theiss-Nyland, M Gurung, B Pokhrel, S Kelly, ... BMJ open 13 (4), e068334, 2023 | | 2023 |
| Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers M Gurung, SM Bijukchhe, P Hariri, M Voysey, R Kandasamy, S Thorson, ... The Pediatric Infectious Disease Journal 40 (10), 937-943, 2021 | | 2021 |
